RYTM

RHYTHM PHARMACEUTICALS INC

RYTM·76243J105·US·Common Stock·Healthcare - Biotechnology-13D/G

RYTM (RHYTHM PHARMACEUTICALS INC) is held by 161 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($740.2M), BlackRock, Inc. ($683.6M), BAKER BROS. ADVISORS LP ($622.3M). Net institutional sentiment: Mixed.

161
Holders
(9 Elite)
$7B
Total Value
54% (167)
Consensus
90 buying - 77 selling
13F: Insider & Congress: Updated regularly
RYTM

Smart Money Verdict

View all
Loading verdict
Held by 161 funds
9 elite

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Aug 17, 2026 · Activists May 15, 2026 · Congress none

InsiderLKLee Jennifer KaydenSell $8.9MAug 13, 2026
InsiderGAGarfield AlastairSell $402KAug 13, 2026
InsiderGAGarfield AlastairSell $182KAug 13, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
6.7M$740.2M6.4%+187.94%
0
Decreased
6.2M(-1.3%)$683.6M0.0%+97.71%
0
Unchanged
5.6M$622.3M3.1%+369.22%
0
Decreased
3.2M(-7.3%)$351.8M0.2%+451.59%
0
Increased
3.1M(+3.2%)$348.3M0.0%+24.00%
32
Increased
3M(+1.3%)$333.8M0.0%+24.53%
31
Increased
2.7M(+70.7%)$292.2M0.0%+14.76%
46
Increased
2.6M(+13.3%)$285.7M0.0%+82.30%
35
Increased
2.2M(+14.5%)$245.2M0.8%+44.02%
49
Increased
2.1M(+8.2%)$236.1M0.0%+69.28%
33
Increased
1.8M(+38.8%)$198.3M0.3%+127.51%
48
Increased
1.7M(+3.0%)$184.7M0.4%+87.93%
38
Increased
1.5M(+8.3%)$170.3M0.0%+204.20%
33
Increased
1.5M(+37.4%)$170.1M0.0%+7.50%
40
Decreased
1.3M(-10.9%)$140.3M0.0%+23.14%
0
Increased
1.1M(+58.0%)$123.5M0.0%+37.37%
43
Decreased
1M(-39.3%)$113.9M0.0%+86.58%
0
Increased
957,785(+43.6%)$106.3M0.1%+32.28%
48
Unchanged
758,891$84.3M0.3%+49.57%
0
Decreased
894,723(-1.7%)$77.8M0.0%+16.97%
0

Showing 1-20 of 175

1 / 9
RYTMRYTMRHYTHM PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used